Loading…
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $55M | $1M | $3M | $0M | 19.3% | 5.2% | -150.2% |
| 2024 | $52M | $3M | $-6M | $8M | -28.1% | 11.0% | -40.6% |
| 2023 | $47M | $9M | $-10M | $10M | -39.4% | -53.6% | -1656.1% |
| 2022 | $101M | $8M | $1M | $2M | 1.9% | - | - |
| 2021 | - | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 101.25 | 46.98 | 52.16 | 54.90 |
| Operating Revenue | - | 99.80 | 45.45 | 50.01 | 53.06 |
| Cost Of Revenue | - | 9.17 | 10.48 | 11.52 | 11.23 |
| Gross Profit | - | 92.08 | 36.50 | 40.65 | 43.67 |
| Operating Expense | - | 90.84 | 36.20 | 42.47 | 44.58 |
| Selling General And Administration | - | 84.20 | 34.92 | 41.10 | 42.93 |
| Total Expenses | - | 100.01 | 46.68 | 53.99 | 55.80 |
| Operating Income | - | 1.24 | 0.30 | -1.82 | -0.91 |
| Total Operating Income As Reported | - | 0.83 | 0.32 | -1.89 | -0.91 |
| EBITDA | - | 7.89 | 8.88 | 2.90 | 0.81 |
| Normalized EBITDA | - | 8.30 | 8.86 | 2.97 | 0.82 |
| EBIT | - | 1.24 | 0.30 | -1.82 | -0.91 |
| Other Non Operating Income Expenses | - | -0.13 | -0.06 | 0.28 | 0.68 |
| Other Income Expense | - | -0.54 | -0.04 | 0.21 | 0.68 |
| Pretax Income | - | 0.70 | 0.25 | -1.61 | -0.23 |
| Tax Provision | - | 0.07 | 11.02 | 0.01 | 0.04 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | -0.04 | 0 | -0.01 | 0 |
| Net Income Continuous Operations | - | 0.63 | -10.77 | -1.61 | -0.27 |
| Net Income From Continuing And Discontinued Operation | - | 0.63 | -9.75 | -5.80 | 2.91 |
| Net Income From Continuing Operation Net Minority Interest | - | 0.63 | -10.77 | -1.61 | -0.27 |
| Net Income | - | 0.63 | -9.75 | -5.80 | 2.91 |
| Net Income Common Stockholders | - | 0.63 | -9.75 | -5.80 | 2.91 |
| Net Income Including Noncontrolling Interests | - | 0.63 | -9.75 | -5.80 | 2.91 |
| Normalized Income | - | 1 | -10.79 | -1.56 | -0.26 |
| Diluted NI Availto Com Stockholders | - | 0.63 | -9.75 | -5.80 | 2.91 |
| Basic Average Shares | - | 14.49 | 14.69 | 14.92 | 15.13 |
| Diluted Average Shares | - | 14.87 | 14.94 | 15.15 | 15.13 |
| Reconciled Depreciation | - | 6.65 | 8.58 | 4.72 | 1.71 |
| Reconciled Cost Of Revenue | - | 9.17 | 3.18 | 8.17 | 11.16 |
| Total Unusual Items | - | -0.41 | 0.02 | -0.07 | -0.01 |
| Total Unusual Items Excluding Goodwill | - | -0.41 | 0.02 | -0.07 | -0.01 |
| Net Income Discontinuous Operations | - | - | 1.02 | -4.18 | 3.18 |
| Special Income Charges | - | -0.41 | 0.02 | -0.07 | -0.01 |
| Depreciation Amortization Depletion Income Statement | - | 6.65 | 1.28 | 1.37 | 1.64 |
| Depreciation And Amortization In Income Statement | - | 6.65 | 1.28 | 1.37 | 1.64 |
| General And Administrative Expense | - | 70.23 | 26.23 | 30.12 | 29.63 |
| Other Gand A | - | 70.23 | 26.23 | 30.12 | 29.63 |
| Gain On Sale Of Ppe | - | -0.41 | 0.02 | -0.07 | -0.01 |
| Selling And Marketing Expense | - | 13.96 | 8.69 | 10.97 | 13.30 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| The Joint Corp.this co. | JYNT | $117M | 40.32 | 7.80 | 19.3% | 118.19 |
| AVITA Medical, Inc. | RCEL | $134M | -2.76 | -8.06 | 291.8% | -4.12 |
| SANUWAVE Health, Inc. | SNWV | $132M | 11.20 | 81.74 | 729.6% | 7.38 |
| MaxCyte, Inc. | MXCT | $132M | -2.95 | 0.77 | -26.0% | -3.23 |
| Aldeyra Therapeutics, Inc. | ALDX | $106M | -3.14 |
| - |
| - |
| - |
| - |
| 2.40 |
| -76.5% |
| -1.63 |
| Cardiff Oncology, Inc. | CRDF | $106M | -2.31 | 2.33 | -101.0% | -1.86 |
| Neuronetics, Inc. | STIM | $102M | -2.61 | 4.54 | -174.3% | -5.84 |
| OptimizeRx Corporation | OPRX | $101M | 19.67 | 0.79 | 4.0% | 6.26 |
| Definitive Healthcare Corp. | DH | $96M | -0.69 | 0.34 | -49.4% | -0.74 |
| Peer Median | - | -2.46 | 1.56 | -37.7% | -1.74 | |